Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626366 · ClinicalTrials.gov registry record · NA
Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00626366: Completed NA study, sponsored by University of Nebraska.
NCT00626366 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00626366, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the distribution of nasal sprays and nasal drops when used.
Primary Outcome
CT scan scored for distribution contrast delivered by nasal spray or drops within subsets in the nasal cavity. The sinonasal cavity was divided into twenty-one subsites on each side of the nasal cavity. The interpreters scored for the presence (1) or absence (0) of contrast from the nasal spray or nasal drops within each subsite. Left and right sides were interpreted separately for a possible total score of 0-42 for each CT scan.
Interventions
- RADIATION Sinus CT Scan
- DRUG Omnipaque 240 Contrast Solution
- DRUG Omnipaque 240 mg I/mL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-03-12 |
| Est. Completion | 2009-01-09 |
| Phase | NA |
What the finished NCT00626366 record still lists
NCT00626366 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Sinus CT Scan is the first listed.
NCT00626366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00626366 about?
NCT00626366 is a clinical study titled "Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison". The purpose of this study is to determine the distribution of nasal sprays and nasal drops when used.
What is the current status of trial NCT00626366?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2008-03-12. Estimated completion is 2009-01-09.
What interventions are being tested in trial NCT00626366?
The interventions under investigation include: Sinus CT Scan (RADIATION), Omnipaque 240 Contrast Solution (DRUG), Omnipaque 240 mg I/mL (DRUG).
Who is sponsoring clinical trial NCT00626366?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00626366's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI